Skip to main content

Table 1 Data collection points at baseline, first annual review and second annual review for participants

From: The Patient Activation through Community Empowerment/Engagement for Diabetes Management (PACE-D) protocol: a non-randomised controlled trial of personalised care and support planning for persons living with diabetes

Study overview

 

Recruitment

Annual Review (AR) 1

AR2

Time point

−3 Month

− 3 Week

−1 Week

Year 0

Year 1

 

Enrolment Visit

Annual Blood Panel

Care Planning Letter

Annual Review Visit

AR2 will be same as AR1 in sequencea

Enrolment:

 Eligibility Screen & Informed Consent

✓

    

Study groups:

 Control

 

✓

 

Standard Care

Y

 Intervention

 

✓

✓

CSP

Y

Variables collected:

Primary outcome

HbA1c

 

✓

  

Y

Secondary outcomes

PAM-13

✓

  

✓

Y

Healthcare Utilisation Survey

✓

  

✓

Y

Healthcare Utilisation, Cost Data

Extracted from medical records, billing information, ePOS, Oracle BI

Other pre-specified outcomes

Body Weight and Blood Pressure

 

✓

 

✓

Y

LDL-cholesterol

 

✓

  

Y

Exercise, smoking status, community resource utilisation

✓

  

✓

Y

Foot and Eye Screening

✓

  

✓

Y

Survey on perception of the new care model (Intervention only)

   

✓

Y

  1. ✓ – Performed, collected, administered through survey (whichever applicable)
  2. Y – Collected or performed in the same order as the various time points and sections detailed under Annual Review 1
  3. aPatient will be returning for their annual blood panel test prior to the annual review. Patients in the Intervention will receive their care planning letter. Following that, the patients will go for the annual review where they receive either the standard care (Control) or CSP (Intervention)